FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law Taking unapproved drugs such as TB 500 and BPC 157 means:, Using DoD prohibited substances, Compromising your readiness to serve, Risking your health and military career, #LetsTalkSupplements RFK Jr. and the Perils of Peptides Washington Monthly